Clinical Trial Update: Exposure Study Comparing 3 Routes of Methotrexate (MTX) Administration [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports Phase 1/2 results from an exposure study comparing three routes of methotrexate administration in rheumatoid arthritis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• METHOTREXATE (METHOTREXATE)

Snippet

Sponsor: Antares Pharma Inc. | Conditions: Rheumatoid Arthritis | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2014-02-25